128 related articles for article (PubMed ID: 36598390)
21. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion.
Chao AN; Shields CL; Krema H; Shields JA
Ophthalmology; 2001 Oct; 108(10):1877-83. PubMed ID: 11581065
[TBL] [Abstract][Full Text] [Related]
22. Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen Lecture.
Shields CL; Alset AE; Boal NS; Casey MG; Knapp AN; Sugarman JA; Schoen MA; Gordon PS; Douglass AM; Sioufi K; Say EA; Shields JA
Am J Ophthalmol; 2017 Jan; 173():106-133. PubMed ID: 27725148
[TBL] [Abstract][Full Text] [Related]
23. Conjunctival Melanoma: Features and Outcomes Based on the Fitzpatrick Skin Type in 540 Patients at a Single Ocular Oncology Center.
Shields CL; Yaghy A; Dalvin LA; Vaidya S; Pacheco RR; Perez AL; Ramesh S; George K; Arias DE; Shiuey EJ; Lally SE; Shields JA
Ophthalmic Plast Reconstr Surg; 2020; 36(5):490-496. PubMed ID: 32134771
[TBL] [Abstract][Full Text] [Related]
24. Conjunctival and uveal melanoma: Survival and risk factors following orbital exenteration.
Baum SH; Westekemper H; Bechrakis NE; Mohr C
Eur J Ophthalmol; 2022 Jan; 32(1):612-619. PubMed ID: 33573425
[TBL] [Abstract][Full Text] [Related]
25. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
26. Secondary orbital exenteration for conjunctival melanoma: A study of 25 cases.
Lemaître S; Lévy-Gabriel C; Dendale R; Vincent-Salomon A; Lumbroso-Le Rouic L; Cassoux N; Couturaud B; Desjardins L
J Fr Ophtalmol; 2021 Mar; 44(3):415-419. PubMed ID: 33573797
[TBL] [Abstract][Full Text] [Related]
27. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients.
Lally SE; Milman T; Orloff M; Dalvin LA; Eberhart CG; Heaphy CM; Rodriguez FJ; Lin CC; Dockery PW; Shields JA; Shields CL
Ophthalmology; 2022 Jun; 129(6):679-693. PubMed ID: 35085662
[TBL] [Abstract][Full Text] [Related]
28. Malignant melanoma of the lacrimal drainage apparatus complicating conjunctival melanoma.
Satchi K; McKelvie P; McNab AA
Ophthalmic Plast Reconstr Surg; 2015; 31(3):207-10. PubMed ID: 25126770
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma.
Yousef YA; Finger PT
Arch Ophthalmol; 2012 May; 130(5):599-606. PubMed ID: 22652846
[TBL] [Abstract][Full Text] [Related]
30. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
31. American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes.
Shields CL; Kaliki S; Al-Dahmash SA; Lally SE; Shields JA
Ophthalmic Plast Reconstr Surg; 2012; 28(5):313-23. PubMed ID: 22965011
[TBL] [Abstract][Full Text] [Related]
32. Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center.
Vaidya S; Dalvin LA; Yaghy A; Pacheco R; Shields JA; Lally SE; Shields CL
Eur J Ophthalmol; 2021 Sep; 31(5):2675-2685. PubMed ID: 33176471
[TBL] [Abstract][Full Text] [Related]
33. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
[TBL] [Abstract][Full Text] [Related]
34. Conjunctival melanoma: association of cyclooxygenase-2 tumor expression to prognosis.
Pinto-Proença R; Santos M; Fonseca C; Fernandes J; Gaspar MF; Proença R
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):989-995. PubMed ID: 29297092
[TBL] [Abstract][Full Text] [Related]
35. [Pathology and prognostic factors of conjunctival melanoma].
Berta-Antalics AI; Kruse FE; Holbach L
Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292
[TBL] [Abstract][Full Text] [Related]
36. Orbital exenteration for conjunctival melanoma: comparison of long-term outcome between individualised and conventional techniques.
Ma R; Ren H; Zhou X; Gan L; Xu B; Guo J; Qian J
Eye (Lond); 2021 Dec; 35(12):3410-3418. PubMed ID: 33608640
[TBL] [Abstract][Full Text] [Related]
37. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases.
Shields CL; Markowitz JS; Belinsky I; Schwartzstein H; George NS; Lally SE; Mashayekhi A; Shields JA
Ophthalmology; 2011 Feb; 118(2):389-95.e1-2. PubMed ID: 20723990
[TBL] [Abstract][Full Text] [Related]
38. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades.
Esmaeli B; Wang X; Youssef A; Gershenwald JE
Ophthalmology; 2001 Nov; 108(11):2101-5. PubMed ID: 11713086
[TBL] [Abstract][Full Text] [Related]
39. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
40. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; J Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
Br J Ophthalmol; 2021 Oct; 105(10):1358-1364. PubMed ID: 32892167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
